Praveen Tyle's most recent trade in Kiora Pharmaceuticals Inc was a trade of 40,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiora Pharma Inc | Praveen Tyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Praveen Tyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Praveen Tyle | Director | Purchase of securities on an exchange or from another person at price $ 3.96 per share. | 19 Aug 2024 | 5,000 | 5,014 (0%) | 0% | 4.0 | 19,800 | Common Stock |
| Kiora Pharma Inc | Praveen Tyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,778 | 1,778 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Praveen Tyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Praveen Tyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) |